🦊/People

Fernando Alarcon

MBA at Ilico Genetics

Greater Philadelphia

Find your path to Fernando

271 people in our graph share verified history with Fernando — schools, employers, funds. One of them is your warm intro.

Lauren ArribasunlockedFernando: together at The Wharton School (2018)
Fernando: together at Villanova University
×9Fernando: together at The Wharton School
Fernando: together at Colliers International | Chile

About

Fernando Alarcon is the co-founder and CEO of Ilico Genetics, a company developing a methylated-DNA liquid biopsy to detect gastric cancer early from a blood draw in high-risk patients, such as those with intestinal metaplasia and atrophic gastritis. The company holds an exclusive license from Pontificia Universidad Católica de Chile, has raised over $1 million, won the Judge's Choice and Audience awards at Ben Franklin Venture Idol 2024, and has begun early engagement with the FDA. Prior to Ilico, Alarcon worked in corporate finance and M&A advisory across Latin America, including valuations, capital raises, and growth strategy in the healthcare and pharmaceutical sectors.

MBA at Ilico Genetics

Intro paths

In turn, Fernando can intro founders to Ilico Genetics's investors below.

Co-founders at Ilico Genetics

Experience

  1. Ilico GeneticsCo-founder & CEOcurrent2019 — present
  2. ATRUS AdvisorsPartner2019 — 2022Greater Philadelphia Area
  3. Sitka AdvisorsCorporate Finance Consultant2015 — 2019Chile
  4. Colliers International | ChileCorporate Finance Consultant2013 — 2015Chile
  5. TuDiseñoCo-Founder2010 — 2013Santiago, Chile
  6. Universidad de los AndesTeaching Assistant2011 — 2012Santiago, Chile
  7. Universidad de los AndesTeaching Assistant2010 — 2011Santiago, Chile
  8. EntelBusiness Intern2011 — 2012Santiago, Chile
  9. Whitetail Ski ResortSki Instructor2010 — 2011Pennsylvania, United States

Skills & more

Microsoft Excel15Microsoft Office2Microsoft PowerPoint6Microsoft Word9Bloomberg1Corporate Finance11M&A experience8Financial Modeling5Business Strategy3Finance4Real Estate1Sales1
+12 moreMarketingBusiness DevelopmentMarket ResearchMarketing ManagementVenture CapitalAccountingBudgetingValuation ModelingEBITDALBOFusiones y adquisicionesElaboración de modelos financieros

Languages English · Portuguese · Spanish

  • Business and Financial Modeling SpecializationUniversity Of Pennsyvania
  • Wharton Business and Financial Modeling CapstoneUniversity Of Pennsyvania
  • Fundamentals of Quantitative ModelingUniversity Of Pennsyvania
  • Introduction to Spreadsheets and ModelsUniversity Of Pennsyvania
  • Modeling Risk and RealitiesUniversity Of Pennsyvania
  • Decision-Making and ScenariosUniversity Of Pennsyvania
  • ASA 114 - Cruising CatamaranAmerican Sailing

From Fernando's professional profile.

Frequently asked questions

Who is Fernando Alarcon?
Fernando Alarcon is the co-founder and CEO of Ilico Genetics, a company developing a methylated-DNA liquid biopsy to detect gastric cancer early from a blood draw in high-risk patients, such as those with intestinal metaplasia and atrophic gastritis. The company holds an exclusive license from Pontificia Universidad Católica de Chile, has raised over $1 million, won the Judge's Choice and Audience awards at Ben Franklin Venture Idol 2024, and has begun early engagement with the FDA. Prior to Ilico, Alarcon worked in corporate finance and M&A advisory across Latin America, including valuations, capital raises, and growth strategy in the healthcare and pharmaceutical sectors.
Where does Fernando Alarcon work?
Fernando Alarcon is MBA at Ilico Genetics.
Where did Fernando Alarcon go to school?
Fernando Alarcon studied at Villanova University (Master of Business Administration - MBA); Universidad de los Andes (CL) (Bachelor’s Degree, Business Administration); The Wharton School (Specialization, Business and Financial Modeling).

Same school

Shared employers